The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
Thomas J. Spoerel, insider at Becton, Dickinson and

Thomas J. Spoerel Insider Information

Thomas J. Spoerel is Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller of the Company. Mr. Spoerel joined BD in September 2015 as Vice President Finance and Deputy Controller, and became Vice President Finance and Controller in December 2018. Prior to joining BD, Mr. Spoerel served as Vice President Finance and Corporate Controller of Catalent, Inc.

What is Thomas J. Spoerel's net worth?

The estimated net worth of Thomas J. Spoerel is at least $272,731.24 as of June 7th, 2022. Mr. Spoerel owns 1,058 shares of Becton, Dickinson and stock worth more than $272,731 as of August 10th. This net worth approximation does not reflect any other assets that Mr. Spoerel may own. Learn More about Thomas J. Spoerel's net worth.

How old is Thomas J. Spoerel?

Mr. Spoerel is currently 44 years old. There are 5 older executives and no younger executives at Becton, Dickinson and. The oldest executive at Becton, Dickinson and is Mr. Samrat S. Khichi Esq., Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel, who is 55 years old. Learn More on Thomas J. Spoerel's age.

How do I contact Thomas J. Spoerel?

The corporate mailing address for Mr. Spoerel and other Becton, Dickinson and executives is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. Becton, Dickinson and can also be reached via phone at (201) 847-6800. Learn More on Thomas J. Spoerel's contact information.

Has Thomas J. Spoerel been buying or selling shares of Becton, Dickinson and?

Thomas J. Spoerel has not been actively trading shares of Becton, Dickinson and during the last quarter. Learn More on Thomas J. Spoerel's trading history.

Who are Becton, Dickinson and's active insiders?

Becton, Dickinson and's insider roster includes Simon Campion (EVP), Alexandre Conroy (EVP), Claire Fraser (Director), John Gallagher (VP), Roland Goette (EVP), David Hickey (EVP), Patrick Kaltenbach (EVP), Samrat Khichi (EVP), Betty Larson (EVP), James Lim (EVP), Thomas Polen, Jr. (Insider), Rebecca Rimel (Director), and Thomas Spoerel (VP). Learn More on Becton, Dickinson and's active insiders.

Are insiders buying or selling shares of Becton, Dickinson and?

During the last year, insiders at the medical instruments supplier sold shares 13 times. They sold a total of 34,678 shares worth more than $9,217,175.00. The most recent insider tranaction occured on June, 7th when VP Thomas J Spoerel sold 443 shares worth more than $115,180.00. Insiders at Becton, Dickinson and own 0.5 % of the company. Learn More about insider trades at Becton, Dickinson and.

Information on this page was last updated on 6/7/2022.

Thomas J. Spoerel Insider Trading History at Becton, Dickinson and

See Full Table

Thomas J. Spoerel Buying and Selling Activity at Becton, Dickinson and

This chart shows Thomas J. Spoerel's buying and selling at Becton, Dickinson and by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Becton, Dickinson and Company Overview

Becton, Dickinson and logo
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Read More

Today's Range

Now: $258.56
Low: $256.24
High: $259.04

50 Day Range

MA: $244.95
Low: $234.16
High: $258.72

2 Week Range

Now: $258.56
Low: $231.46
High: $280.62

Volume

725,852 shs

Average Volume

1,198,708 shs

Market Capitalization

$73.74 billion

P/E Ratio

44.58

Dividend Yield

1.36%

Beta

0.59
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!